Overview

Assessing Neuropsychiatric Symptoms Including Depression, Anxiety, Irritability, and Suicidal Thoughts or Behavior in Subjects Quitting Smoking on Varenicline Tartrate or Placebo

Status:
Completed

Trial end date:
2009-08-01

Target enrollment:

Participant gender:

Summary

Study objective is to compare neuropsychiatric adverse events in subjects treated with varenicline or placebo in a controlled setting where both groups are experiencing nicotine withdrawal.

Phase:

Phase 4

Details

Lead Sponsor:

Pfizer

Treatments:

Varenicline